Stocktoria

Nautilus Biotechnology, Inc. NAUT

Nasdaq · stock · Laboratory Analytical Instruments · website · IPO 2020-08-07

Nautilus Biotechnology, Inc. statistics & valuation

Market cap$254.2M
P / B1.6×
Return on equity-37.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-13.80% -18.40% -24.00% -33.90% -37.60% 202020212022202320242025
Shares outstanding
33.1M 124.3M 124.9M 125.1M 126.1M 126.5M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-18.40% -12.60% -16.50% -20.80% -29.20% -30.90% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$0.54 -$0.60 -$0.46 -$0.51 -$0.56 -$0.47 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-30.9%-29.2%-20.8%-16.5%-12.6%-18.4%
Return on equity-37.6%-33.9%-24.0%-18.4%-13.8%52.6%
Current ratio13.3317.4019.3927.5760.0925.73

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.